Capital Advisory Group Advisory Services’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	–	–	515
2022 Q1	$0	Buy	+3	New	+$438	﹤0.01%	521
2021 Q4	–	Sell	-3	Closed	-$2K	–	551
2021 Q3	$2K	Hold	3	–	–	﹤0.01%	514
2021 Q2	$2K	Hold	3	–	–	﹤0.01%	512
2021 Q1	$2K	Hold	3	–	–	﹤0.01%	492
2020 Q4	$2K	Hold	3	–	–	﹤0.01%	500
2020 Q3	$1K	Hold	3	–	–	﹤0.01%	487
2020 Q2	$1K	Hold	3	–	–	﹤0.01%	457
2020 Q1	$0	Buy	+3	New	+$543	﹤0.01%	490
2019 Q4	–	Sell	-3	Closed	-$1K	–	448
2019 Q3	$1K	Hold	3	–	–	﹤0.01%	436
2019 Q2	$0	Hold	3	–	–	﹤0.01%	455
2019 Q1	$1K	Hold	3	–	–	﹤0.01%	418
2018 Q4	$0	Hold	3	–	–	﹤0.01%	432
2018 Q3	$1K	Hold	3	–	–	﹤0.01%	370
2018 Q2	$2K	Hold	3	–	–	﹤0.01%	327
2018 Q1	$3K	Buy	+3	New	+$2.51K	﹤0.01%	307

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Advisory Group Advisory Services's AMPE Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 3 shares.

Capital Advisory Group Advisory Services first reported a position in AMPE in Q1 2018 and held it in 15 quarters. The position peaked at $3K in Q1 2018. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

Capital Advisory Group Advisory Services reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 3 Ampio Pharmaceuticals Inc. shares in Q2 2022.
Capital Advisory Group Advisory Services first reported a position in Ampio Pharmaceuticals Inc. in Q1 2018 and held it in 15 quarters.
Capital Advisory Group Advisory Services's Ampio Pharmaceuticals Inc. position peaked at $3K in Q1 2018.
111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.